Canadian Stroke Best Practice Recommendations: Vascular cognitive impairment, 7th edition practice guidelines update, 2024

IF 13 1区 医学 Q1 CLINICAL NEUROLOGY Alzheimer's & Dementia Pub Date : 2025-01-16 DOI:10.1002/alz.14324
Richard H. Swartz, R. Stewart Longman, M. Patrice Lindsay, Rebecca Lund, Aravind Ganesh, Gail A. Eskes, Melissa Austin, Lauren E. Bechard, Jaspreet Bhangu, Venera C. Bruto, Sherri Carter, Nelly Chow, Yan Deschaintre, Kathleen Fedorchuk, Lesley Fellows, Norine Foley, Lee-Anne Greer, Douglas S. Lee, Carol Leonard, Ronak Patel, Sepideh Poonyania, Valerie Poulin, Fatima Quraishi, Pamela Roach, Tricia Shoniker, Carmen Tuchak, Anita Mountain, Chelsy Martin, Eric E. Smith, the Canadian Stroke Best Practice Recommendations Advisory Committee, in collaboration with the Canadian Stroke Consortium, Canadian Neurological Sciences Federation, and CanStroke Recovery Trials Platform
{"title":"Canadian Stroke Best Practice Recommendations: Vascular cognitive impairment, 7th edition practice guidelines update, 2024","authors":"Richard H. Swartz,&nbsp;R. Stewart Longman,&nbsp;M. Patrice Lindsay,&nbsp;Rebecca Lund,&nbsp;Aravind Ganesh,&nbsp;Gail A. Eskes,&nbsp;Melissa Austin,&nbsp;Lauren E. Bechard,&nbsp;Jaspreet Bhangu,&nbsp;Venera C. Bruto,&nbsp;Sherri Carter,&nbsp;Nelly Chow,&nbsp;Yan Deschaintre,&nbsp;Kathleen Fedorchuk,&nbsp;Lesley Fellows,&nbsp;Norine Foley,&nbsp;Lee-Anne Greer,&nbsp;Douglas S. Lee,&nbsp;Carol Leonard,&nbsp;Ronak Patel,&nbsp;Sepideh Poonyania,&nbsp;Valerie Poulin,&nbsp;Fatima Quraishi,&nbsp;Pamela Roach,&nbsp;Tricia Shoniker,&nbsp;Carmen Tuchak,&nbsp;Anita Mountain,&nbsp;Chelsy Martin,&nbsp;Eric E. Smith,&nbsp;the Canadian Stroke Best Practice Recommendations Advisory Committee, in collaboration with the Canadian Stroke Consortium, Canadian Neurological Sciences Federation, and CanStroke Recovery Trials Platform","doi":"10.1002/alz.14324","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <p>The Canadian Stroke Best Practice Recommendations (CSPR) 7th edition includes this new module on the diagnosis and management of vascular cognitive impairment (VCI) with or without neurodegenerative disease. An expert writing group and people with VCI lived experience (PWLE) reviewed current evidence. Existing recommendations were reviewed and revised, and new recommendations added. Sections include definitions, signs and symptoms, screening, assessment, diagnosis, pharmacological and non-pharmacological management, secondary prevention, rehabilitation, and end-of-life care. PWLE were actively involved in all aspects of the development, ensuring their experiences are integrated. A unique VCI journey map, developed by PWLE, is included, and helped to motivate and anchor the recommendations. We encourage it to be displayed across healthcare settings to raise awareness and support persons with VCI. These VCI CSBPRs emphasize the need for integrated multidisciplinary care across the continuum. Evidence for the diagnosis and management of VCI continues to emerge and gaps in knowledge should drive future research.</p>\n </section>\n \n <section>\n \n <h3> Highlights</h3>\n \n <div>\n <ul>\n \n <li>This Canadian Stroke Best Practice Recommendations module focuses specifically on VCI using a structured framework and validated methodology.</li>\n \n <li>A comprehensive set of evidence-based recommendations is presented that addresses the continuum from symptom onset to diagnosis, management, and end of life.</li>\n \n <li>The recommendations consider individuals who experience VCI because of stroke or because of other vascular pathologies such as atrial fibrillation or heart failure.</li>\n \n <li>A journey map of an individual's experience with VCI has been developed by individuals with lived experience. It is a valuable guide to inform educational content, approaches to caring for individuals and families with VCI, and systems planning.</li>\n </ul>\n </div>\n </section>\n </div>","PeriodicalId":7471,"journal":{"name":"Alzheimer's & Dementia","volume":"21 1","pages":""},"PeriodicalIF":13.0000,"publicationDate":"2025-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/alz.14324","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alzheimer's & Dementia","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/alz.14324","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

The Canadian Stroke Best Practice Recommendations (CSPR) 7th edition includes this new module on the diagnosis and management of vascular cognitive impairment (VCI) with or without neurodegenerative disease. An expert writing group and people with VCI lived experience (PWLE) reviewed current evidence. Existing recommendations were reviewed and revised, and new recommendations added. Sections include definitions, signs and symptoms, screening, assessment, diagnosis, pharmacological and non-pharmacological management, secondary prevention, rehabilitation, and end-of-life care. PWLE were actively involved in all aspects of the development, ensuring their experiences are integrated. A unique VCI journey map, developed by PWLE, is included, and helped to motivate and anchor the recommendations. We encourage it to be displayed across healthcare settings to raise awareness and support persons with VCI. These VCI CSBPRs emphasize the need for integrated multidisciplinary care across the continuum. Evidence for the diagnosis and management of VCI continues to emerge and gaps in knowledge should drive future research.

Highlights

  • This Canadian Stroke Best Practice Recommendations module focuses specifically on VCI using a structured framework and validated methodology.
  • A comprehensive set of evidence-based recommendations is presented that addresses the continuum from symptom onset to diagnosis, management, and end of life.
  • The recommendations consider individuals who experience VCI because of stroke or because of other vascular pathologies such as atrial fibrillation or heart failure.
  • A journey map of an individual's experience with VCI has been developed by individuals with lived experience. It is a valuable guide to inform educational content, approaches to caring for individuals and families with VCI, and systems planning.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
加拿大卒中最佳实践建议:血管认知障碍,第七版实践指南更新,2024年
加拿大卒中最佳实践建议(CSPR)第7版包括关于血管认知障碍(VCI)伴或不伴神经退行性疾病的诊断和管理的新模块。一个专家写作小组和有VCI生活经验(PWLE)的人审查了目前的证据。对现有建议进行了审查和修订,并增加了新的建议。章节包括定义、体征和症状、筛选、评估、诊断、药理学和非药理学管理、二级预防、康复和临终关怀。PWLE积极参与开发的各个方面,确保他们的经验得到整合。其中包括由PWLE开发的独特的VCI旅程图,它有助于激励和确定建议。我们鼓励在整个医疗保健环境中展示它,以提高对VCI患者的认识并为他们提供支持。这些VCI csbpr强调需要跨连续体的综合多学科护理。诊断和管理VCI的证据不断出现,知识上的差距应推动未来的研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Alzheimer's & Dementia
Alzheimer's & Dementia 医学-临床神经学
CiteScore
14.50
自引率
5.00%
发文量
299
审稿时长
3 months
期刊介绍: Alzheimer's & Dementia is a peer-reviewed journal that aims to bridge knowledge gaps in dementia research by covering the entire spectrum, from basic science to clinical trials to social and behavioral investigations. It provides a platform for rapid communication of new findings and ideas, optimal translation of research into practical applications, increasing knowledge across diverse disciplines for early detection, diagnosis, and intervention, and identifying promising new research directions. In July 2008, Alzheimer's & Dementia was accepted for indexing by MEDLINE, recognizing its scientific merit and contribution to Alzheimer's research.
期刊最新文献
Response to the letter titled reply to “Associations of semaglutide with first-time diagnosis of Alzheimer's disease in patients with type 2 diabetes: Target trial emulation using nationwide real-world data in the US” Reply to “Associations of semaglutide with first-time diagnosis of Alzheimer's disease in patients with type 2 diabetes: Target trial emulation using nationwide real-world data in the US” Prevalence of idiopathic normal pressure hydrocephalus in older adult population in Shanghai, China: A population-based observational study Influence of alpha-synuclein on glucose metabolism in Alzheimer's disease continuum: Analyses of α-synuclein seed amplification assay and FDG-PET A brain DNA co-methylation network analysis of psychosis in Alzheimer's disease
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1